Brief: Onconetix Sets Stage For Potential Business Combination With Ocuvex Therapeutics
08/04/2025 14:25
April 8 (Reuters) - Onconetix and Ocuvex Therapeutics: ONCONETIX SIGNS LETTER OF INTENT FOR POTENTIAL BUSINESS COMBINATION WITH OCUVEX THERAPEUTICS, INC. ONCONETIX- POST CLOSE, PRE-CLOSING OCUVEX EQUITY HOLDERS WILL OWN ABOUT 90% OF EQUITY INTERESTS IN ONCONETIX ONCONETIX INC - ONCONETIX AND OCUVEX WILL CONTINUE NEGOTIATIONS TO ENTER INTO A DEFINITIVE AGREEMENT Source text: ID:nGNX4KTqqm ((Reuters.Briefs@thomsonreuters.com;))